Author(s)
PIYUSH JATINBOS KAJALE
- Manuscript ID: 140731
- Volume: 2
- Issue: 6
- Pages: 3133–3141
Subject Area: Other
Abstract
Antipsychotics are recommended as the initial, evidence-based treatment for schizophrenia and other primary psychotic disorders. Some antipsychotics are also approved for conditions such as bipolar disorder, treatment-resistant depression, autism, and Tourette's disorder. They are commonly prescribed off-label for conditions like borderline personality disorder, obsessive-compulsive disorder, anorexia nervosa, insomnia, delirium, and various forms of dementia including Alzheimer's disease. However, the effectiveness of these medications can be limited by their side effects, which need to be carefully balanced against their varying therapeutic benefits across these conditions.[3] Consequently, discussions about these medications often focus more on their side effects rather than their therapeutic benefits.